Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
35%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
THNR
18
HOLDINGS
39%
ALSO IN MEDX
MEDX
27
HOLDINGS
26%
ALSO IN THNR
SECTOR DRIFT (THNR minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.1% | 18.8% | 10.1% |
|
ABBVIE INC | 5.1% | 9.6% | 5.1% |
|
MERCK & CO. INC. | 5.1% | 4.7% | 4.7% |
|
AMGEN INC | 5.5% | 4.6% | 4.6% |
 |
ASTRAZENECA PLC | 5.4% | 4.6% | 4.6% |
THNR Overweight Relative to MEDX
 |
NOVO-NORDISK A/S-SPONS ADR | 8.4% |
|
VIKING THERAPEUTICS, INC. | 5.5% |
 |
CHINA PHARMACEUTICAL GROUP | 5.3% |
 |
INNOVENT BIOLOGICS, INC. | 5.3% |
|
GILEAD SCIENCES INC | 5.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 4.9% |
|
ZEALAND PHARMA A/S | 4.0% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 4.0% |
 |
HANMI PHARM CO LTD | 3.6% |
|
REGENERON PHARMACEUTICALS | 2.4% |
THNR Underweight Relative to MEDX
|
ELI LILLY & CO | -8.7% |
 |
NOVARTIS AG-ADR | -6.6% |
|
JOHNSON & JOHNSON | -6.2% |
|
BRISTOL-MYERS SQUIBB CO | -4.5% |
 |
ALKERMES PLC | -4.4% |
|
ABBVIE INC | -4.4% |
|
BIOGEN IDEC INC | -3.4% |
|
ALNYLAM PHARMACEUTICALS INC | -3.0% |
|
CRISPR THERAPEUTICS AG | -2.7% |
|
IONIS PHARMACEUTICALS, INC. | -2.6% |